Testosterone treatment in older men reduced anemia but did not improve cognitive function, and was associated with a significant increase in arterial plaque, according to Northwestern Medicine clinical trials.
A JAMA study has found that hemoglobin A1C measurements — a biomarker frequently used to diagnose diabetes — may be less accurate in African-Americans with sickle cell trait.
With evidence-based smartphone apps developed by our Center for Behavioral Intervention Technologies, mental healthcare is always within reach.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
A panel of experts gathered to discuss strategies for preventing violence among young men in Chicago, at an event sponsored by the Institute for Public Health and Medicine and the Office of Diversity and Inclusion.
Sandra Sanguino, ’93 MD, MPH, associate dean for Student Affairs, has received the Exceptional Mentor Award from the American Medical Women’s Association.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.
In recent Northwestern Medicine clinical trials, an experimental drug improved survival rates for patients with advanced midgut neuroendocrine tumors compared to a standard therapy.
A paper published in Molecular Cell provides new insight into a protein complex called COMPASS and its function during histone methylation, a key modification that regulates gene expression.
Joseph Bass, MD, PhD, chief of Endocrinology, Metabolism and Molecular Medicine, focuses his research on illuminating how the body’s clocks regulate feeding behavior and glucose metabolism, and identifies how disruptions in that overarching circadian system play a role in metabolic disease.